EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report

Angelica Aja Dangca Alcoreza, Cheryn Song, Junyeop Lee

Frontiers in Oncology · 09.07.2026 · 16

DOI: 10.3389/fonc.2026.1870341 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 09.07.2026. Verfasst von Angelica Aja Dangca Alcoreza und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Quirino Memorial Medical Center, Quezon City, Philippines. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To report a case of retinal capillary hemangioblastoma (RCH) regression in a patient with von Hippel–Lindau (VHL) disease following treatment with systemic belzutifan. Case presentation A 49-year-old female with VHL disease presented with a retinal capillary hemangioblastoma in the left eye that had been previously treated with laser therapy. She subsequently developed a new retinal lesion and interval growth of a renal intraparenchymal mass, for which systemic belzutifan was initiated. Four months after treatment initiation, a reduction in the size of the retinal lesions was observed, along with decreased perfusion and vascularity.

Conclusion

Systemic belzutifan therapy for VHL disease may induce regression of retinal capillary hemangioblastomas and can be effective as either a primary or an adjunctive treatment modality.

Schlagwörter

Stichwörter der Autor:innen

HIF-2α inhibitorbelzutifanrenal cell carcinomaretinal capillary hemangioblastomavon Hippel-Lindau disease

Autor:innen und Institutionen

  • Department of Ophthalmology, Quirino Memorial Medical Center, Quezon City, Philippines.
  • Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Alcoreza, A. A. D., Song, C., & Lee, J. (2026). Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1870341

Vancouver

Alcoreza AAD, Song C, Lee J. Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1870341

BibTeX
@article{Alcoreza2026,
  author = {Alcoreza, Angelica Aja Dangca and Song, Cheryn and Lee, Junyeop},
  title = {Regression of retinal capillary hemangioblastoma with systemic belzutifan in von Hippel–Lindau disease: a case report},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1870341}
}
Kostenlos starten →